<DOC>
	<DOCNO>NCT02552316</DOCNO>
	<brief_summary>The ASPIRE study clinical trial design examine microbe ( e.g. , bacteria ) within psoriasis skin lesion compare normal skin . The investigator also examine effect NB-UVB ( narrow-band ultraviolet B ) phototherapy ( i.e. , light therapy ) skin microbe .</brief_summary>
	<brief_title>Psoriasis Microbiome Phototherapy</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>1 . Males females 18 year age old . 2 . Clinical diagnosis psoriasis least 6 month determine subject interview his/her medical history confirmation diagnosis physical examination Investigator . 3 . Stable plaque psoriasis least 2 month Screening Baseline ( Week 1 ) determine subject interview his/her medical history . 4 . Subject candidate phototherapy . 5 . Subject least one psoriatic plaque measure least 6cm x 2cm locate either arm leg ( exclude intertriginous area axilla inguinal fold ) 6 . Able willing give write informed consent comply requirement study protocol . 1 . Subject photosensitize condition contraindication phototherapy 2 . Diagnosis erythrodermic psoriasis , generalize localized pustular psoriasis , medicationinduced medicationexacerbated psoriasis , new onset guttate psoriasis . 3 . Can discontinue avoid topical therapy psoriasis least 14 day prior Baseline ( Week 1 ) visit study face , underarms , groin . 4 . Can discontinue avoid UVB phototherapy Excimer laser least 14 day prior Baseline ( Week 1 ) visit . 5 . Subject receive therapy psoriasis require wash period 14 day ( e.g. , psoralenUVA phototherapy , oral systemic therapy , biologic therapy , investigational therapy ) . 6 . Other active inflammatory dermatologic condition ( e.g. , eczema ) presence pustular erythrodermic psoriasis . 7 . Any history acute chronic bacterial , fungal , viral infection ( include HIV , hepatitis , tuberculosis , severe recurrent infection ) within 30 day baseline sample collection . 8 . Subject use systemic ( oral parenteral ) antibiotic , antimycotic , antiviral within 3 month topical antibiotic , antimycotic , antiviral within 14 day baseline sample collection require use topical systemic antibiotic , antimycotic , antiviral study . 9 . Consumption large dos commercial probiotic ( great equal 108 cfu organism per day ) include tablet , capsule , lozenge , chew gum powder probiotic primary component . Ordinary dietary component ferment beverages/milks , yogurt , food apply . 10 . Presence comorbid medical condition ( e.g. , HIV , malignancy within past 5 year successfully treat basal cell carcinoma , nonmetastatic cutaneous squamous cell carcinoma cervical carcinoma insitu ) significantly alter immune system result immunosuppression . 11 . Subject taking ( within 180 day baseline sample collection ) require topical systemic therapy study significantly alter immune system result immunosuppression ( e.g. , chemotherapy , oral injectable corticosteroid ) . Inhaled corticosteroid stable medical condition allow . 12 . Unstable dietary history define major change diet within 30 day baseline study , subject plan eliminate significantly increase major food group diet . 13 . Recent history substance abuse psychiatric illness could preclude compliance protocol . 14 . History substance abuse within 365 day screen visit . 15 . Female subject pregnant breastfeeding consider become pregnant study . 16 . Major surgery gastrointestinal tract , exception cholecystectomy appendectomy , past 5 year . Any major bowel resection time . 17 . History active uncontrolled gastrointestinal disorder diseases include : Inflammatory bowel disease include ulcerative colitis , Crohn 's disease , indeterminate colitis ; Irritable bowel syndrome ; Persistent , infectious gastroenteritis , colitis , gastritis , persistent chronic diarrhea unknown etiology , Clostridium difficile infection ( recurrent ) Helicobacter pylori infection ( untreated ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>microbiome</keyword>
	<keyword>bacteria</keyword>
	<keyword>NB-UVB Phototherapy</keyword>
	<keyword>light therapy</keyword>
</DOC>